New York Medical Marijuana News
New York regulators publicly identified the 52 allegedly illicit marijuana stores that were sent cease-and-desist letters earlier this year and reiterated how such shops undercut the state’s equity goals.
Canopy Growth settled a trademark dispute with French orange liqueur producer Rémy Cointreau, which argued that the Canada-based cannabis producer’s line of “Quatreau” beverages infringed on the Cointreau trademark.
New York regulators installed a chief equity officer, a key step to the state’s plan to develop a diverse, multibillion-dollar recreational marijuana industry.
Cannabis multistate operator iAnthus Capital Holdings closed a previously announced restructuring and recapitalization deal, then disclosed $25 million in new financing via senior secured notes.
The state of New York has chosen “premier minority-led investment team” Social Equity Impact Ventures to manage its $200 million marijuana industry social equity investment fund.
To take advantage of LGBTQ Pride month, cannabis retailers are running product promotions tied to the celebration, selling Pride-themed marijuana strains and hanging rainbow flags in their stores to show their support.
A cannabis investor sued Florida regulators for allegedly approving a request by private equity firm Gotham Green Partners to have ownership positions in two vertically integrated medical marijuana licenses in the state.
